论文部分内容阅读
FDA批准Alkermes和Cephalon两家公司每月用药1次的环丙甲羟二羟吗啡酮(naltrexone,Vivitrol)注射剂治疗酒精中毒,同时辅以心理学治疗。Vivitrol是FDA唯一批准用于酒精中毒的延释制剂。两公司希望本品能克服以前每日口服制剂所产生的依从性问题。环丙甲羟二羟吗啡酮片剂一直作为酒精中毒治疗药在市场上销售。Vivitrol为肌肉注射剂,由Alkermes公司生产, Cephalon公司负责销售。Vivitrol不会导致成瘾性。它在大脑内与阿片样物质结
FDA approved Allermes and Cephalon companies to administer naltrexone (Vivitrol) once a month to treat alcoholism, supplemented with psychotherapy. Vivitrol is the only FDA approved extended release agent for alcoholism. The two companies hope that this product can overcome the previous compliance issues arising from oral preparations. Neonatine tablets have been marketed as alcohol poisoning therapies. Vivitrol is an intramuscular injection manufactured by Alkermes and sold by Cephalon. Vivitrol does not cause addiction. It is in the brain and opioid knot